Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Taisho Pharmaceutical
Taisho Pharmaceutical
Activities:
Pharmaceutical
Active Nutrition
Food
X
LinkedIn
Trending Articles
Serialisation and data connectivity: Part I
The new wrinkle in your supply chain
Liquid versus lyophilised: overcoming the challenges of high-potency formulations in modern pharma
Formulating highly potent (HiPo) compounds presents unique challenges that require expertise and precise decision making
SGS’s Shanghai Health Science laboratory completes US FDA inspection with zero 483 observations
SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an...
Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche
Acquisition extends Lonza’s US Biologics footprint with a significant presence on the West Coast, complementing its existing global manufacturing network
SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme
Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Research & Development
Ablynx and Taisho Pharmaceutical enter agreement to develop rheumatoid arthritis drug in Japan
Ablynx will receive an upfront payment of US$3m
Subscribe now